Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zist Mahsool Parsian (operating under the brand Lactovgene) is an Iranian knowledge-based biotechnology and nanotechnology company founded in 2018. The company operates as both a specialized manufacturer of probiotic, pharmaceutical, and veterinary products and as the country's first accelerator in microbial biotechnology, food, and probiotic production. Leveraging the extensive native microbial strain bank of its parent company, Takgene Zist, Lactovgene develops and commercializes advanced formulations for human health, veterinary care, cosmetics, and animal feed. Its commercial product portfolio includes probiotic supplements like BioBoost, BioZen D, and BioCalci D, as well as the vaginal suppository BioBoric.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zist Mahsool Parsian.